Merit Medical Systems Inc MMSI
We take great care to ensure that the data presented and summarized in this overview for MERIT MEDICAL SYSTEMS INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding MMSI
View all-
Black Rock Inc. New York, NY9.51MShares$765 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.82MShares$549 Million0.01% of portfolio
-
William Blair Investment Management, LLC Chicago, IL3.04MShares$245 Million0.62% of portfolio
-
State Street Corp Boston, MA2.24MShares$180 Million0.01% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO2.19MShares$176 Million2.06% of portfolio
-
Conestoga Capital Advisors, LLC2.17MShares$175 Million2.4% of portfolio
-
Fuller & Thaler Asset Management, Inc. San Mateo, CA1.46MShares$117 Million0.49% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.32MShares$106 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA1.29MShares$104 Million0.01% of portfolio
-
Macquarie Group LTD Australia, C31.25MShares$100 Million0.11% of portfolio
Latest Institutional Activity in MMSI
Top Purchases
Top Sells
About MMSI
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.
Insider Transactions at MMSI
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 16
2024
|
Thomas James Gunderson |
BUY
Grant, award, or other acquisition
|
Direct |
2,431
+10.08%
|
-
|
May 16
2024
|
Lonny J Carpenter |
BUY
Grant, award, or other acquisition
|
Direct |
2,431
+13.78%
|
-
|
May 16
2024
|
Stephen C. Evans |
BUY
Grant, award, or other acquisition
|
Direct |
2,431
+20.11%
|
-
|
May 16
2024
|
Michael R Mcdonnell |
BUY
Grant, award, or other acquisition
|
Direct |
2,431
+23.89%
|
-
|
May 16
2024
|
Lynne Ward |
BUY
Grant, award, or other acquisition
|
Direct |
2,431
+18.57%
|
-
|
May 16
2024
|
Silvia Perez |
BUY
Grant, award, or other acquisition
|
Direct |
2,431
+50.0%
|
-
|
May 16
2024
|
F. Ann Millner |
BUY
Grant, award, or other acquisition
|
Direct |
2,431
+6.98%
|
-
|
May 16
2024
|
David Floyd |
BUY
Grant, award, or other acquisition
|
Direct |
2,431
+21.49%
|
-
|
May 16
2024
|
Laura S. Kaiser |
BUY
Grant, award, or other acquisition
|
Direct |
2,431
+23.89%
|
-
|
Mar 14
2024
|
Brian G. Lloyd CHIEF LEGAL OFFICER, SECRETARY |
SELL
Bona fide gift
|
Direct |
1,180
-4.58%
|
-
|
Mar 12
2024
|
Raul Parra Jr. CFO AND TREASURER |
SELL
Open market or private sale
|
Direct |
6,480
-17.8%
|
$479,520
$74.22 P/Share
|
Mar 07
2024
|
Joseph Wright CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
25,000
-37.19%
|
$1,875,000
$75.68 P/Share
|
Mar 07
2024
|
Joseph Wright CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+27.11%
|
$700,000
$28.2 P/Share
|
Mar 06
2024
|
Neil Peterson CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+33.6%
|
$330,000
$44.8 P/Share
|
Mar 06
2024
|
Michel James Voigt CHIEF HUMAN RESOURCES OFFICER |
SELL
Bona fide gift
|
Direct |
315
-3.08%
|
-
|
Mar 04
2024
|
Michel James Voigt CHIEF HUMAN RESOURCES OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,630
-20.46%
|
$199,880
$76.51 P/Share
|
Mar 04
2024
|
Michel James Voigt CHIEF HUMAN RESOURCES OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
12,338
+41.63%
|
-
|
Mar 04
2024
|
Joseph Wright CHIEF COMMERCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,630
-5.86%
|
$199,880
$76.51 P/Share
|
Mar 04
2024
|
Joseph Wright CHIEF COMMERCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
14,429
+14.96%
|
-
|
Mar 04
2024
|
Neil Peterson CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
7,319
+50.0%
|
-
|
Last 12 Months Summary
Grant, award, or other acquisition | 128K shares |
---|---|
Exercise of conversion of derivative security | 317K shares |
Open market or private sale | 101K shares |
---|---|
Payment of exercise price or tax liability | 160K shares |
Bona fide gift | 4.32K shares |